![Screenshot of title and primary endpoint of plain language media summary on SUNNY trials results Screenshot of title and primary endpoint of plain language media summary on SUNNY trials results](/sites/novartis_com/files/styles/webp/public/2023-02/primary-endpoint-media-summary-sunny-trials-results-preview.jpg.webp?itok=9IDaHZpO)
Description
Discover the data published in The Lancet on the long-term effect of Cosentyx® (secukinumab) in adults with hidradenitis suppurativa from the SUNRISE and SUNSHINE trials.
Usage Rights & Restrictions
This media asset is free for editorial broadcast, print, online and radio use. It is restricted for other purposes.